CRON
Cronos Group Inc.·Healthcare
2.72
0.366%(−0.01)
Close PriceLast Updated: — ET
52W L: $1.8452W H: $3.43
CRON NEWS
marijuanastocks.com
5d ago
Top Canadian Marijuana Stock Choices For Better Investing In 2026
Many marijuana stock investors have a strong positive outlook on the future of the market. If you've been watching the cannabis sector, then you know how volatile and uncertain trading can be. Yet there have been changes that give more upside to what the future of investing can hold. As cannabis is now a class 3 substance federally, more companies are making shifts in their business to get in line with this new legislation.
seekingalpha.com
May 14
Cronos: Strong Q1 Earnings Driven By International Cannabis Sales
Cronos reported strong Q1 performance with record level revenue. International sales are driving growth and the Canadian markets are showing improvement. The company is set to acquire CanAdelaar in the Netherlands which will increase its international operations and revenue potential.
seekingalpha.com
May 13
Cronos: Excellent M&A And Favorable Valuation Make This A Buy (Upgrade)
Cronos Group Inc. reported Q1 '26 revenue up 40% to $45 million, exceeding estimates. Despite strong top-line growth, CRON posted a small operating loss of $1.8 million, with net income driven by interest and FX gains. CapEx dropped sharply by 87% year-over-year to $1.9 million, reflecting tighter capital discipline.
seekingalpha.com
May 11
Cronos Group Inc. (CRON:CA) Q1 2026 Earnings Call Transcript
Cronos Group Inc. (CRON:CA) Q1 2026 Earnings Call Transcript
marketbeat.com
May 11
Cronos Group Q1 Earnings Call Highlights
Cronos Group NASDAQ: CRON reported record first-quarter 2026 net revenue and gross profit, with management pointing to growth in Israel, gains for its Spinach brand in Canada and continued international expansion as key drivers of the quarter.
zacks.com
May 11
Cronos Group (CRON) Q1 Earnings Meet Estimates
Cronos Group (CRON) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.02 per share a year ago.
